Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)

NCT02708186 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Dementia With Lewy Bodies
REM Sleep Behavior Disorder
Parkinson's Disease Dementia

Interventions

DRUG: Nelotanserin
DRUG: Placebo

Sponsor

Axovant Sciences Ltd.